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ARTICLE OPEN
Three-dimensional low shear culture of Mycobacterium bovis
BCG induces biofilm formation and antimicrobial drug
tolerance
Daire Cantillon1, Justyna Wroblewska1, Ian Cooper 2, Melanie J. Newport1 and Simon J. Waddell 1✉
Mycobacteria naturally grow as corded biofilms in liquid media without detergent. Such detergent-free biofilm phenotypes may
reflect the growth pattern of bacilli in tuberculous lung lesions. New strategies are required to treat tuberculosis, which is
responsible for more deaths each year than any other bacterial disease. The lengthy 6-month regimen for drug-sensitive
tuberculosis is necessary to remove antimicrobial drug tolerant populations of bacilli that persist through drug therapy. The role of
biofilm-like growth in the generation of these sub-populations remains poorly understood despite the hypothesised clinical
significance and mounting evidence of biofilms in pathogenesis. We adapt a three-dimensional Rotary Cell Culture System to model
M. bovis BCG biofilm growth in low-shear detergent-free liquid suspension. Importantly, biofilms form without attachment to
artificial surfaces and without severe nutrient starvation or environmental stress. Biofilm-derived planktonic bacilli are tolerant to
isoniazid and streptomycin, but not rifampicin. This phenotypic drug tolerance is lost after passage in drug-free media.
Transcriptional profiling reveals induction of cell surface regulators, sigE and BCG_0559c alongside the ESX-5 secretion apparatus in
these low-shear liquid-suspension biofilms. This study engineers and characterises mycobacteria grown as a suspended biofilm,
illuminating new drug discovery pathways for this deadly disease.
npj Biofilms and Microbiomes            (2021) 7:12 ; https://doi.org/10.1038/s41522-021-00186-8
INTRODUCTION
Mycobacterium tuberculosis (M. tb), the causative agent of
tuberculosis (TB), was responsible for 1.5 million deaths in 20181.
The 6-month treatment for drug-sensitive TB combines four
antimicrobial drugs: isoniazid, rifampicin, pyrazinamide and
ethambutol. However, one third of all antimicrobial drug resistant
(AMR) infections globally are caused by M. tb2. Drug-resistant TB
often requires longer treatment with less effective and more toxic
drug combinations, such as the aminoglycoside streptomycin3.
The necessity of lengthy drug therapy is attributed to the
presence of phenotypically antimicrobial drug tolerant M. tb
sub-populations that arise due to M. tb metabolic and respiratory
adaptations to the diverse intracellular and extracellular micro-
environments encountered during infection4,5. Phenotypic drug
tolerance is a temporary, reversible state in bacteria often linked
to reduction in cell division rate, where antimicrobial drugs are
ineffective despite bacilli being genetically susceptible6. Drug
tolerant bacilli have been identified in ex vivo leporine lung lesion
caseum and in sputa from TB patients7–10. A number of in vitro
models have been developed to mimic clinically relevant
microenvironments to determine the impact of hypoxia or
nutrient starvation on M. tb physiological state and drug
efficacy11–13. However, these models alone do not capture the
complexity of M. tb growth in lung lesions, where anti-TB drugs
are directed.
Mycobacteria have long been recognised to grow in macro-
scopic aggregates in vivo and in vitro, as long chains of cells,
known as cording. Georges Canetti described M. tb growth as
“exuberant” multicellular structures reminiscent of biofilms in
histological examination of human TB lung lesions14. M. tb has also
been observed growing as clusters or microcolonies in the
acellular rim of granulomas in the guinea pig model of infection,
even after treatment with anti-tuberculous drugs15. Such aggrega-
tions of mycobacteria likely act as an axenic biofilm, with local
microenvironments created by nutrient or oxygen gradients
driving bacterial phenotypic diversity and generating potentially
antimicrobial drug tolerant populations, recalcitrant to drug
therapy. This corded biofilm-like phenotype is overlooked by
most in vitro mycobacterial research, where detergent is added to
liquid media to enhance bacterial enumeration and increase
experimental reproducibility.
Since Ojha et al.16 demonstrated that M. tb biofilms formed at
the liquid-air interface harbour antimicrobial drug tolerant bacilli,
research into the role of biofilms in TB pathogenesis has
expanded. Mycobacterial biofilm models, often based on the
formation of a pellicle at the liquid–air interface, have demon-
strated that mycobacteria in biofilm-like structures are less
sensitive to antimicrobial drug exposure, show biofilm architec-
ture and an extracellular matrix readily identifiable by microscopy,
and express distinct transcriptional profiles when compared to
planktonic growth16–19. These systems often rely on attachment to
artificial surfaces or exposure to stringent environmental condi-
tions to create biofilm-like structures. The use of 3D cell culture
systems are increasingly applied across a range of disciplines, as
they allow in vivo environments to be more closely replicated
in vitro. This enhances the formation of complex cellular structures
and microarchitecture, of importance when considering biofilm
formation. M. tb in an electrospray 3D granuloma model,
generated using primary human cells and a collagenous extra-
cellular matrix, exhibited drug sensitivities similar to in vivo drug
efficacies, including sensitivity to pyrazinamide that is not
observed in standard in vitro culture20. Non scaffold-based 3D
1Global Health and Infection, Brighton and Sussex Medical School, University of Sussex, Brighton BN1 9PX, UK. 2School of Pharmacy & Biomolecular Sciences, University of
Brighton, Brighton BN2 4GJ, UK. ✉email: s.waddell@bsms.ac.uk
www.nature.com/npjbiofilms













culture offers increased opportunities for complex structures to
emerge in liquid suspension and may be particularly relevant to
the study of respiratory pathogens. Pseudomonas aeruginosa in
ex vivo lung tissues from people with cystic fibrosis formed
biofilms that were not surface-attached to host epithelial tissue
but free-floating aggregates of cells in the mucus of the bronchial
lumen21. Non-attached P. aeruginosa in vitro biofilms have similar
characteristics to in vivo biofilms, including adaptations that result
in antimicrobial drug tolerance22.
The Rotary Cell Culture System (RCCS) was originally developed
by the National Aeronautics and Space Administration (NASA) as a
rotating vessel bioreactor to investigate the impact of micro-
gravity on cellular processes23. The rotating low shear environ-
ment enables growing cell clusters to form with enhanced
multicellular structural complexity without surface attachment,
alongside high rates of nutrient, waste and gaseous exchange
superior to 2D models24,25. This ensures that the biological
adaptations to biofilm-like growth are in response to nutrient,
waste or gas gradients in three dimensions via apical, lateral and
basal surfaces of the growing aggregation of cells26. A key feature
of the RCCS culture system is that 3D cellular structures are
allowed to develop without any destructive mechanical shear
forces that would be introduced through media changes or
aeration in standard culture models27. The system has been used
to generate complex, hierarchical cellular structures for eukaryotic
tissues and for host–pathogen interaction studies28.
Here, we developed a three-dimensional liquid suspension cell
culture system to model mycobacterial corded biofilm-like growth.
M. bovis BCG biofilm-derived bacilli were tolerant to key anti-
tuberculosis drugs and supernatant from biofilms induced a
greater pro-inflammatory macrophage response. Transcriptomics
highlighted cell surface regulatory elements and ESX-5 type VII
secretion components as likely mediating adaptations to a biofilm
substructure. These findings suggest that detergent-free corded
biofilm-like growth may facilitate the development of drug
tolerant phenotypes observed in vivo.
RESULTS
Three-dimensional low shear culture generates a
mycobacterial biofilm phenotype
To understand the physiology of M. tb bacilli that grow in biofilm-
like structures that might mimic extracellular growth in pulmonary
lung lesions, we developed a three-dimensional suspended liquid
culture biofilm model. The Rotary Cell Culture System (RCCS), first
developed by NASA to assay cellular adaptations to microgravity,
was optimised for Mycobacterium bovis BCG. In this low shear
rotary culture system, clusters of bacilli grow together suspended
in liquid detergent-free Sauton media. As the aggregation of
mycobacteria falls through the vessel, centrifugal and Coriolis
effects from rotation counter gravity maintaining the three-
dimensional biofilm permanently in suspension (Fig. 1a). Unlike
other biofilm models, this system enabled the natural cord-
forming mycobacterial phenotype to develop without attachment
to an artificial solid medium, nor reliance on an air/liquid interface
for pellicle formation16,18,19,29. Mycobacterial biofilms were macro-
scopically visible in rotating RCCS vessels, as was the accumulation
of biomass in the bottom of non-rotating vessels by day 21 (Fig.
1b/d). As expected, microscopy revealed extensive cording of
acid-fast bacilli in RCCS-biofilm cultures in comparison to non-
rotating (control) culture (Fig. 1c/e). Scanning electron microscopy
showed a compact and complex biofilm macrostructure, with
densely packed bacilli looped into corded structures coated with
extracellular material (Fig. 2). RCCS-biofilm growth resulted in a
more compact matrix of bacilli with a greater extent of
extracellular material. This biofilm phenotype was generated
without excessive aging or nutrient starvation. The RCCS vessels
are designed to allow passive diffusion of gases through a
posterior silicone membrane, permitting mycobacterial colonies to
grow as cords suspended in liquid media. The model therefore
allowed the direct impact of enhanced biofilm architecture on the
formation of antimicrobial drug tolerant phenotypes to be
investigated.
Fig. 1 Three-dimensional low shear Rotary Cell Culture System (RCCS) generates a mycobacterial biofilm phenotype. a The RCCS
disposable vessel with entry ports to the front and gas permeable membrane and rotation fixing to rear. Centrifugal force (Fcf ) is controlled
through rotation speed enabling biomass to grow without encountering the vessel walls. Gravity (g) in non-rotating controls collects biomass
to the bottom of the vessel. b M. bovis BCG RCCS-biofilm formed after 21 days. c Heavily corded Kinyoun-stained RCCS-biofilm after 21 days.
d Biomass in non-rotating control at the bottom of the vessel after 21 days (vessel agitated for imaging). e Kinyoun-stained non-rotating
control with limited cording after 21 days. White scale bar is 1 cm, black scale bar is 20 µM.
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Biofilm-derived bacilli are tolerant to the antimicrobial drugs
isoniazid and streptomycin
The clinically relevant antimicrobial drugs, isoniazid, rifampicin
and streptomycin (targeting cell wall biosynthesis, transcription
and translation, respectively) were used as tools to characterise
the metabolic adaptations caused by biofilm formation. RCCS-
biofilm and non-rotating control bacilli were first homogenised to
single-cell suspensions before assessing antimicrobial drug
efficacy, to negate the impact of physical barriers created by
biofilm growth. Importantly, we show that planktonic suspensions
of bacilli derived from biofilms exhibited drug tolerance to
isoniazid and streptomycin, but not rifampicin, in comparison to
non-rotating control cultures (Fig. 3a–c). Reduction in isoniazid
and streptomycin antimicrobial activity was observed at multiple
drug concentrations. We hypothesise that the compact cording
seen in RCCS-biofilm cultures (Fig. 2) generates greater popula-
tions of drug-tolerant bacilli, which remain phenotypically drug-
tolerant even as single cells in suspension. To demonstrate that
this loss of cidal drug action was phenotypically mediated rather
than the emergence of genetically encoded drug resistance, RCCS-
biofilm and non-rotating control cultures were passaged three
times in drug-free media (with detergent) before assaying drug
activity as before. All bacilli were equally sensitive to the three
antimicrobial drugs (Fig. 3d–f), establishing that loss of drug
activity against biofilm-derived bacilli was due to phenotypic
adaptations that induced drug tolerance. Biofilm formation affords
bacteria protection from environmental insults including anti-
microbial drug exposure, and previous mycobacterial biofilm
models have demonstrated drug tolerance16,19. These models
treated biofilms directly with antimicrobial drugs without homo-
genisation, so the impact of biofilm formation on mycobacterial
phenotype, as opposed to drug penetration into the biofilm, was
not directly assessed as in this study.
Biofilm-derived cells were tolerant to isoniazid and streptomy-
cin but not rifampicin. Isoniazid, a first line antitubercular drug, is
most effective against replicating bacilli, where the FasII cycle
target is essential for cell wall biosynthesis30. Drug tolerance is
observed in non-replicating or slowly replicating populations,
where the target likely becomes non-essential to mycobacterial
viability31. Reduced isoniazid efficacy in this model suggests that
RCCS-biofilm growth generates greater proportions of non- or
slowly-replicating populations of bacilli, or creates populations of
bacilli with modified cell wall constituents, that are tolerant to
isoniazid even after the substructure of the biofilm is destroyed.
Streptomycin has some bactericidal activity against non-dividing
stationary phase bacteria32, however we observed a reduction
in drug efficacy in biofilm-derived relative to non-rotating
control bacilli. The presence of a biofilm-associated extracellular
matrix has been shown to reduce aminoglycoside efficacy in
P. aeruginosa33, and streptomycin exerts poor activity against
intracellular mycobacteria5. Further experiments will be required
to determine if streptomycin tolerance in this model is due to
decreased penetration of drug or reduced importance of the
target pathway. Rifampicin, a first line TB drug, has been shown to
be highly effective against M. tb biofilms, reducing viability >1000
fold, but failing to eradicate a subset of bacilli that persisted
through drug exposure16. Rifampicin tolerance was not observed
in our RCCS-biofilm model, showing that a large proportion of
bacilli found in the biofilm structure were transcriptionally active.
This underscores the novelty of this system, enabling corded
mycobacterial growth without extensive nutrient depletion steps
or exogenous environmental stress. The drug-tolerant phenotype
demonstrated here, derived from enhanced mycobacterial aggre-
gation, may mimic M. tb biofilm formation that has been observed
in lung lesions14,15,34, in potentially nutrient replete surroundings
where bacilli have adapted to replicate successfully.
The biofilm transcriptome reveals key regulatory adaptations
to the cell surface
To understand the impact on gene expression of growth in an
enhanced corded biofilm, the transcriptome of RCCS-biofilm bacilli
was contrasted to standardised log (day 5) and stationary phase
(day 21) bacilli grown in Sauton media without detergent. The
RNA profiles of biofilm-derived bacilli clustered most closely to
stationary phase M. bovis BCG signatures (Fig. 4a/b). In addition,
the average Pearson correlation, measuring the similarity between
conditions, of RCCS-biofilm was most similar to stationary phase
(0.89, in comparison with 0.86 to log phase). Therefore, to define
adaptations driven specifically by biofilm-like cellular aggregation
rather than growth rate, we identified genes differentially
expressed in RCCS-biofilm relative to stationary phase bacilli; 14
genes were significantly induced greater than 2-fold in biofilms
Fig. 2 Biofilm macrostructure reveals densely packed bacilli looped into corded structures. Scanning electron microscopy of a–c RCCS-
biofilm and d–f. non-rotating M. bovis BCG control. RCCS-biofilm shows more compact growth with enriched topology and higher deposition
of extracellular matrix. Scale bar is 20 µM in all images.
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(Fig. 4a/c). The transcriptional signature of biofilm formation was
dominated by genes involved in the regulation of transcription
and translation, evidenced by significant enrichment of the gene
annotation functional category (II.A) Synthesis and Modification of
Macromolecules35, and GO term (GO:0008135) Translation Factor
Activity, Nucleic Acid Binding (hypergeometric probabilities of
2.71 × 10−5 and 1.54 × 10−5 respectively). The alternative sigma
factors sigB and sigE, that control mycobacterial responses to
environmental cues such as nutrient starvation and cell surface
stress, were induced. Interestingly, both sigB and sigE null mutants
are more sensitive to isoniazid and streptomycin but not
rifampicin36, mirroring our biofilm drug tolerance phenotype
and implicating these regulatory factors as key mediators of the
adaptations to biofilm growth. BCG_0559c (Rv0516c), a putative
anti-anti-sigma factor, was also upregulated in RCCS-biofilm
relative to stationary phase. This regulatory protein likely mediates
responses to osmotic stress, with disruption leading to reduced
thickness of the peptidoglycan layer in the M. tb cell wall37. We
hypothesise that induction of this putative osmoregulator high-
lights changes to the microenvironments surrounding bacilli as
they grow together in a biofilm-like structure. Of note, these
regulators (sigB, sigE and Rv0516c) were also induced in the
formation of M. tb biofilms generated by exposure to dithiothreitol
(DTT)19. Also induced in RCCS-biofilm was greA, a transcription
elongation factor that enables RNA polymerase to overcome
blocks caused by RNA-DNA hybrids. Knockdown of greA
abrogated pellicle formation and reduced biofilm-like growth in
M. smegmatis38. Induction of the translation initiation factor, infA,
and S12 and S20 30S ribosomal proteins, encoded by rpsL
(targeted by streptomycin) and rpsT respectively, that form part of
the translation machinery suggest that bacilli were metabolically
active in the enhanced RCCS-biofilm macrostructure.
Genes of the mycobacterial ESX-5 type VII secretion system
(esxJ, esxM and upstream PE19) were induced in biofilm-derived
compared to stationary phase bacilli. The ESX-5 apparatus, found
only in slow-growing mycobacterial species, is responsible for the
secretion of multiple substrates including PE/PPE proteins. Of
note, ESX-5, in M. marinum, has been implicated in the activation
of the macrophage inflammasome and the release of pro-
inflammatory cytokines, supporting a role for this secretion
apparatus in mediating host immune responses39. The system
has also been demonstrated to be involved in adjusting cell wall
permeability and in the uptake of hydrophobic carbon sources40.
Isocitrate lyase, icl1, required in the glyoxylate shunt and
methylcitrate cycles that are upregulated in macrophages and in
sputa, was also induced41, suggesting that biofilm growth drives a
lipolytic metabolic response comparable to M. tb in vivo. In
summary, biofilm formation in free-fall suspension caused
adaptations to cell surface control systems, exemplified by
induction of sigE and BCG_0559c, in comparison to stationary
phase culture in the absence of detergent. Significantly, sigE and
elements of the ESX-5 secretion system (esxJ, esxM, PE19 found
here, plus esxN, BCG_1826 and esxK) were also found to be
induced when M. bovis BCG cells first began to aggregate in a
Sauton no detergent model of pellicle formation18, highlighting
these systems as likely mediators of the dynamic mycobacterial
phenotypes generated in biofilm-like growth.
Induction of the ESX-5 secretion apparatus in RCCS-biofilm
bacilli suggested that growth as a biofilm may result in the
differential secretion of mycobacterial effector molecules, which
might alter interactions with host immune cells. Therefore, we
Fig. 3 Biofilm-derived bacilli are tolerant to isoniazid and streptomycin. a–c RCCS-biofilm (circle) or non-rotating control (square) bacilli
were homogenised to single cell suspensions and exposed to isoniazid, streptomycin or rifampicin. Biofilm-derived bacilli showed enhanced
survival to isoniazid and streptomycin, but not rifampicin. d–f This drug tolerant phenotype was lost after passage in drug-free media. Area
under the curve (AUC) plots illustrating the difference in drug efficacy over multiple drug concentrations are detailed alongside each plot.
Percentage survival calculated relative to untreated bacilli. Error bars are ±standard error of the mean from two biological replicates each with
duplicate technical replicates. *p value ≤ 0.05; **p value ≤ 0.01.
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tested whether filter-sterilised supernatant from RCCS-biofilm or
non-rotating control bacilli was cytotoxic to, or induced differ-
ential cytokine release in, differentiated human THP-1 macro-
phages. Neither supernatants (10% v/v) from day 7 nor day 21
biofilm or control bacilli caused detectable macrophage loss
(Supplementary Fig. 2a). There was no significant difference in IL-
1β secretion. However, TNFα release was significantly greater after
exposure to RCCS-biofilm day 21 supernatant compared to non-
rotating control M. bovis BCG (Supplementary Fig. 2b). TNFα, a key
pro-inflammatory cytokine released by alveolar macrophages, is
fundamental to orchestrating granuloma formation in the lung in
response to M. tb, however overproduction may lead to excessive
immunopathology42. Greater induction of TNFα by RCCS-biofilm
supernatant may suggest that mycobacterial corded growth
modifies the secretion of effector molecules that could alter the
interactions between host and pathogen. Further biochemical
characterization of this response will determine whether it is
dependent on the ESX-5 type VII secretion system in M. tb.
DISCUSSION
An improved understanding of the M. tb phenotypes present
in vivo will aid rational drug discovery for a disease that continues
to newly infect 10 million people each year. Here, we exploited the
natural cord-forming ability of M. bovis BCG to develop a low shear
liquid biofilm model to mimic mycobacterial growth in lung
tissue. Importantly, the model allowed bacilli to grow as corded
structures in suspension without applying nutrient starvation,
aging, or environmental stress. This permitted the phenotype of
bacilli grown as a corded biofilm to be defined separate from
divergent and overlapping adaptations to dramatic changes in the
microenvironment. We hypothesised that biofilm-like growth
would generate diverse phenotypes of bacilli as the aggregations
of bacteria expanded, analogous to M. tb colonies observed in
pulmonary lung lesions. Bacilli liberated from biofilms demon-
strated phenotypic drug tolerance to the anti-TB drugs isoniazid
and streptomycin. Cell surface regulatory factors SigE and
BCG_0559c (Rv0516c) and the ESX-5 secretion system were
implicated in mediating the response to biofilm growth, and
these adaptations resulted in a greater pro-inflammatory response
from macrophages exposed to biofilm supernatants. Thus, we
conclude that the natural ability to cord is alone sufficient to
induce antimicrobial drug tolerance in vitro (Fig. 5). We
hypothesise that this phenomenon also generates phenotypic
heterogeneity in vivo, leading to populations of bacilli that persist
through drug therapy necessitating the current 6-month treat-
ment regimen for TB.
Biofilms are widely implicated in chronic infections in humans.
Biofilm formation protects its bacterial inhabitants against
environmental insults, antimicrobial agents, and the host immune
response, and it is a key pathogenic process for many bacteria.
Biofilms are implicated in urinary tract, soft tissue, pulmonary and
surgical implant infections43–45. Traditional 2D culture poorly
predicts clinical activity of new drugs, and the development of 3D
culture methods that more accurately reflect the in vivo environ-
ment offers new avenues for drug discovery46. The addition of
detergents to mycobacterial media is common practice to
encourage homogenous bacterial culture, and while this facilitates
Fig. 4 Mycobacterial transcriptional response to growth as a corded biofilm. a Volcano plot showing transcriptional adaptations to biofilm
growth comparing RCCS-biofilm to stationary phase bacilli (red, induced in biofilm; blue, repressed). b Dendrogram of three biological
replicates of RCCS-biofilm alongside log phase and stationary phase controls. Hierarchical clustering of mean-centred significantly
differentially expressed genes to highlight differences between RNA signatures. c Genes significantly induced by biofilm growth, detailing
M. bovis BCG and M. tb identifiers. Ordered by BCG ID.
D. Cantillon et al.
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reproducible in vitro research, it does not accurately reflect the
growth state of mycobacteria in vivo. The development of new
tools to engineer, characterise and screen mycobacterial biofilms
in detergent-free systems18,47 may lead to the discovery of new
transformative drugs targeted where they are required, at drug-




Mycobacterium bovis BCG Pasteur was cultured at 37 °C in Middlebrook
7H9 broth (Sigma Aldrich) supplemented with albumin dextrose catalase
(ADC) (10% v/v) and Tween 80 (0.05% v/v), or in Sauton media with or
without Tween 80 (0.05% v/v). Sauton media was prepared by dissolving
0.5 g potassium phosphate, 0.5 g magnesium sulphate, 4 g L-asparagine,
2 g citric acid, 0.05 g ferric ammonium citrate and 60ml glycerol in 900ml
of water. The pH was adjusted to 7.2 before autoclaving at 121 °C for
15min and addition of 100 µL sterile 1% zinc sulphate. Optical density was
measured using a spectrophotometer at absorbance 600 nm. Colony
forming units (CFU) were determined by serially diluting cultures onto
Middlebrook 7H10 agar (Sigma Aldrich) supplemented with 0.5% glycerol
and oleic acid albumin dextrose catalase (10% v/v) and incubating at 37 °C
for four weeks. Microscopy for acid-fast bacilli was performed by Kinyoun
staining (Becton Dickinson GmbH, Oxford, UK) following manufacturer’s
instructions. Bacilli were imaged at 40X magnification using an Axiovert
40CFL light microscope (Zeiss, Cambridge, UK). Images were captured
using Axiovision SE64 software, version 4.9.1.
Biofilm model
Mycobacterial biofilms were generated using the Rotary Cell Culture
System (RCCS-4DQ) with power supply and tachometer to independently
control the rotation of four disposable High Aspect Ratio (HARV) bioreactor
vessels (Synthecon, Houston, USA). To prepare the RCCS inoculum, M. bovis
BCG was passaged from frozen stock into Middlebrook 7H9 ADC with
Tween 80, then cultured for 7 days in Sauton media with Tween 80
(Supplementary Fig. 1). The use of defined Sauton media will allow media
constituents to be easily manipulated, for example modifying carbon and
nitrogen sources. This culture was diluted to an OD 600 nm 0.05–0.06 (106
cells/ml) with Sauton media no Tween 80 before adding to the RCCS
vessels that had been equilibrated with sterile PBS overnight. The vessels
were incubated with (RCCS) or without (control) rotation at 15 rpm in a
37 °C humidified incubator. The rotation of the vessels was adjusted to
counter the sedimentation of growing mycobacterial clusters pulled
downwards by gravity, allowing biofilms to form in a low shear
environment through continuous suspension. The cultures (RCCS-biofilms
and non-rotating controls) were harvested on day 21.
Scanning electron microscopy
Samples were fixed for scanning electron microscopy (SEM) with 100%
glutaraldehyde at 2.5% v/v final volume and incubated at room
temperature for 2 h. The samples were dehydrated by critical point drying
using a graded series of ethanol. After sputter-coating with gold, samples
were imaged using a Leica Leo Stereoscan 420 scanning electron
microscope at 5 kV with 10pA probe current x 124 to 5000.
Determination of antimicrobial drug efficacy
Isoniazid and streptomycin were prepared as 10mg/ml stock solutions in
sterile dimethyl sulfoxide (DMSO). Rifampicin was prepared in 90% w/v
methanol. RCCS-derived biofilm and non-rotating control cultures were
needle homogenised to planktonic suspensions and adjusted to OD
600 nm 0.005, corresponding to 105 CFU/ml. Microtitre plates containing
ranges of antimicrobial drug concentrations in duplicate were inoculated
and incubated for seven days at 37 °C. CellTiter-Blue (Promega) was added
at a final concentration of 10% v/v and incubated overnight. Fluorescence
was measured at excitation 580–640 nm and emission 520 nm using a
Synergy HT plate reader. Fluorescence data were corrected for background
using media-only controls. Percentage survival was calculated relative to
untreated bacilli. To determine between phenotypic drug tolerance or the
emergence of genetically-encoded drug resistance, the RCCS-biofilm and
non-rotating control inoculums (prepared for the drug efficacy assays)
were passaged three times in drug-free 7H9 ADC media (with Tween),
before reassessing drug activity as described above.
RNA extraction and mycobacterial transcriptomics
Mycobacteria were recovered using a guanidine thiocyanate (GTC)/Trizol
extraction method as previously described48. RNA was extracted by bead-
beating with 0.1 mm silica beads for 45 s at speed 6.5 m/s (MP Biomedicals,
Santa Ana, USA), followed by chloroform extraction and RNA purification
using the mirVana RNA isolation kit (ThermoFisher Scientific). Mycobacter-
ial RNA was treated with DNase I (Primerdesign, Southampton, UK), and
RNA yield and quality assessed using the NanoDrop ND-1000 Spectro-
photometer (NanoDrop Technologies) and Agilent 2100 Bioanalyzer
(Agilent Technologies). RNA samples were directly labelled with Cy3
fluorophore using the Universal Linkage System (ULS, Kreatech Diagnos-
tics), as previously described49, and hybridised to high density Agilent
tiling arrays with 180,000 60-mer oligonucleotides evenly tiled across the
M. tb H37Rv genome, designed by the Bacterial Microarray Group at St
George’s, University of London (ArrayExpress accession A-BUGS-47).
Expression ratios were generated by averaging the antisense probes for
each gene in the M. bovis BCG Pasteur genome. RNA from three
independent biological replicates of RCCS-biofilm were contrasted to log
phase (day 5; OD 0.400 ± 0.053, ~7 × 106 CFU/mL) and stationary phase
(day 21, OD 0.580 ± 0.040, ~2 × 108 CFU/mL) bacilli, cultured in triplicate in
static Sauton media no Tween 80.
Macrophage culture and cytokine quantification
Human THP-1 monocytes were cultured in RPMI 1640 medium
supplemented with 10% v/v heat inactivated foetal calf serum and
2mM L-glutamine at 37 °C in a 5% CO2 humidified incubator. THP-1 cells
were differentiated into phagocytic macrophage-like cells by stimulation
with 20 ng/ml (final concentration) phorbol 12-myristate 13-acetate
overnight. The macrophage monolayer was washed and incubated for a
further 48 h before exposure to mycobacterial culture supernatants for
24 h. Supernatants (filter-sterilised after removal from RCCS-biofilm and
non-rotating control vessels) or media only controls were diluted to 10%,
25% or 50% v/v with RPMI for viability testing or 10% v/v for cytokine
Enzyme-Linked Immunosorbent Assays (ELISA) assays. THP-1 cell viability
was assessed using CellTiter-Blue as described above, incubating for 2 h
before data acquisition. ELISA assays determined IL-1β and TNFα release
after macrophage exposure to mycobacterial culture supernatants or
10 ng/ml lipopolysaccharide (LPS), using matched (capture and detection
antibody pair) anti-IL-1β and anti-TNFα human antibodies (R&D Systems).
Streptavidin horseradish peroxidase conjugate was used with its
chromogenic substrate 3, 3′, 5, 5′-tetramethylbenzidine. Absorbance
was measured at 450 nm with a Synergy HT plate reader with wavelength
correction of 540 nm; concentrations were determined from IL-1β and
TNFα standard curves.
Fig. 5 Mycobacterial cording as a biofilm in detergent-free liquid
media. A false-colour scanning electron microscopy image of
M. bovis BCG grown in detergent-free liquid media (magnification
×1000), exemplifying the dense cording phenotype that may better
represent M. tb lung lesion growth, which is quite different from
single cells found in liquid media containing detergent.
D. Cantillon et al.
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Statistical methods
Statistically significant differences in drug efficacy between RCCS-biofilm
and non-rotating controls were determined using a paired parametric t-
test from two biological replicates each with 2–3 technical replicates per
antimicrobial drug concentration using GraphPad Prism 8. Area under the
curve (AUC) for these plots was determined by multiplying % survival by
the drug concentration in µg/ml, baseline Y= 0 in GraphPad Prism 8.
Pearson correlation was applied to measure the similarity in transcriptional
pattern between growth conditions, calculating the average correlation of
biological replicates between conditions from 3,752 gene expression
ratios. Significantly differentially expressed genes were identified using a
moderated t-test (p-value < 0.05 with Benjamini and Hochberg multiple
testing correction) and fold change >2 in GeneSpring 12.6 (Agilent
Technologies) comparing RCCS-biofilm bacilli to stationary phase bacilli
(Supplementary Table 1). Significant overlaps in transcriptional signatures
were identified using hypergeometric probability. Statistical significance in
cytokine ELISAs was determined using an unpaired parametric t-test, p
value < 0.01.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
DATA AVAILABILITY
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